African Journal of
Biotechnology

  • Abbreviation: Afr. J. Biotechnol.
  • Language: English
  • ISSN: 1684-5315
  • DOI: 10.5897/AJB
  • Start Year: 2002
  • Published Articles: 12487

Full Length Research Paper

Association of serum MMP-9 with recurrence in patients with resectable esophageal squamous cell carcinoma after chemotherapy or concurrent radiotherapy

Xu Heng
  • Xu Heng
  • Jiangsu Province Institute of Materia Medica, Nanjing Tech University, Nanjing, Jiangsu, 210000, P.R. China.
  • Google Scholar
Xu Xuyun
  • Xu Xuyun
  • Nanjing Rontia Clinical Laboratory, Nanjing, Jiangsu, 210000, P.R. China.
  • Google Scholar
Du Mengjie
  • Du Mengjie
  • Nanjing Rontia Clinical Laboratory, Nanjing, Jiangsu, 210000, P.R. China.
  • Google Scholar
Ma Rong
  • Ma Rong
  • Research Center For Clinical Oncology, Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research and Nanjing Medical University Affiliated Cancer Hospital, Nanjing, Jiangsu 210000, P. R. China.
  • Google Scholar
Wang Qiang
  • Wang Qiang
  • Department of Radiation Oncology, Xuzhou Cancer Hospital, Xuzhou, Jiangsu 221005, P. R. China.
  • Google Scholar
Du Aonan
  • Du Aonan
  • Department of Radiation Oncology, Xuzhou Cancer Hospital, Xuzhou, Jiangsu 221005, P. R. China.
  • Google Scholar


  •  Received: 03 July 2022
  •  Accepted: 17 August 2022
  •  Published: 31 August 2022

How to cite this article

APA /
Xu, H., Xu, X., Du, M., Ma, R., Wang, Q., & Du, A. (2022). Association of serum MMP-9 with recurrence in patients with resectable esophageal squamous cell carcinoma after chemotherapy or concurrent radiotherapy. African Journal of Biotechnology , 21(8), 387-395.
Chicago /
Xu Heng, Xu Xuyun, Du Mengjie, Ma Rong, Wang Qiang and Du Aonan. "Association of serum MMP-9 with recurrence in patients with resectable esophageal squamous cell carcinoma after chemotherapy or concurrent radiotherapy." African Journal of Biotechnology 21, no. 8 (2022): 387-395.
MLA /
Xu Heng, et al. "Association of serum MMP-9 with recurrence in patients with resectable esophageal squamous cell carcinoma after chemotherapy or concurrent radiotherapy." African Journal of Biotechnology 21.8 (2022): 387-395.